- Mittlere Strasse 91
- CH-4031 Basel, Switzerland
At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. IOB started operations in 2018.
The institute is constituted as a foundation, granting academic freedom to its scientists.
IOB is guided by the Board of Trustees (general rules and strategy), the Scientific Advisory Board (scientific advice and strategy) and the Executive Board (leadership and operations). The Executive Board consists of three co-directors who share the responsibility of guiding the new organization.
More about the IOB
